- Patients with a history of prior malignancy with the exception of non-melanoma skin cancer, carcinoma in situ of the cervix, in situ carcinoma of the bladder, or other malignancy diagnosed > 5 years ago that has undergone potentially curative therapy with no evidence of disease for the last > 5 years and that is deemed by the investigator to be a low risk for recurrence